Yahoo! Finance: RPTP NewsCopyright (c) 2013 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=rptpLatest Financial News for Raptor Pharmaceutical Corp.en-USThu, 09 May 2013 14:02:26 GMThttp://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gifYahoo! Finance: RPTP Newshttp://finance.yahoo.com/q/h?s=rptp14445RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Results of Operations and Financial Conditionhttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130509/rptp8-k.htmlyahoo_finance/387803694Thu, 09 May 2013 14:02:26 GMTRaptor Pharmaceutical Reports First Quarter Calendar Year 2013 Financial Resultshttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/raptor-pharmaceutical-reports-first-quarter-200500781.html[GlobeNewswire] - NOVATO, Calif. -- Raptor Pharmaceutical Corp. (Raptor or the Company) today reported financial results for its first quarter ended March 31, 2013.yahoo_finance/4080707740Wed, 08 May 2013 20:05:00 GMTRAPTOR PHARMACEUTICAL CORP Files SEC form 10-Q, Quarterly Reporthttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130508/rptp10-q.htmlyahoo_finance/172195170Wed, 08 May 2013 13:37:44 GMT3 Healthcare Stock Stories For Tuesday Investment Wellnesshttp://us.rd.yahoo.com/finance/external/xwscheats/rss/SIG=1355p36rb/*http://wallstcheatsheet.com/stocks/3-healthcare-stock-stories-for-tuesday-investment-wellness.html/?ref=YFyahoo_finance/648536538Wed, 08 May 2013 03:55:04 GMTRaptor licenses IP for Rett Syndrome from French Research Institutehttp://us.rd.yahoo.com/finance/external/theflyonthewall/rss/SIG=14c2h163b/*http://www.theflyonthewall.com/permalinks/entry.php/RPTPid1828613/RPTP-Raptor-licenses-IP-for-Rett-Syndrome-from-French-Research-Instituteyahoo_finance/3316788524Tue, 07 May 2013 11:29:24 GMTRaptor Pharmaceutical Licenses Intellectual Property for Rett Syndrome From French Research Instituteshttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/raptor-pharmaceutical-licenses-intellectual-property-110000807.html[GlobeNewswire] - Raptor Expands its Cysteamine Rights for the Treatment of Neurologic Disordersyahoo_finance/2614971502Tue, 07 May 2013 11:00:00 GMTThis Week in Biotechhttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12frm84eu/*http://www.fool.com/investing/general/2013/05/04/this-week-in-biotech-25.aspx?source=eogyholnk0000001yahoo_finance/3262775371Sat, 04 May 2013 20:05:00 GMTTwo Different Outlooks for Two Tuesday Performershttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=1371jc7qa/*http://beta.fool.com/briannichols/2013/05/02/two-different-outlooks-for-two-tuesday-performers/33108/?source=eogyholnk0000001yahoo_finance/2076784505Thu, 02 May 2013 21:20:40 GMTRaptor Pharmaceuticals downgraded to Neutral from Outperform at Wedbushhttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/raptor-pharmaceuticals-downgraded-neutral-outperform-112457178.htmlyahoo_finance/1362003444Thu, 02 May 2013 11:24:57 GMTMultimedia Now Available: Raptor Pharmaceutical's PROCYSBI™ Receives FDA Approval for the Treatment of Nephropathic Cystinosishttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/multimedia-now-available-raptor-pharmaceuticals-201800405.html[PR Newswire] - NOVATO, Calif., May 1, 2013 /PRNewswire/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) ...yahoo_finance/1645515061Wed, 01 May 2013 20:18:00 GMTWall Street Transcript Interview with Boris Peaker, Executive Director and Senior Analyst at Oppenheimer & Co. Inc.: Finding Innovation in Biotechnology for Cell Therapy, Oncology and Orphan Drugshttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/wall-street-transcript-interview-boris-150600805.htmlyahoo_finance/2144549091Wed, 01 May 2013 15:06:00 GMTRAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreementhttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130501/rptp8-k.htmlyahoo_finance/1025411126Wed, 01 May 2013 13:22:34 GMT3 Healthcare Stock Stories For Tuesday Portfolio Wellnesshttp://us.rd.yahoo.com/finance/external/xwscheats/rss/SIG=134b8hrc3/*http://wallstcheatsheet.com/stocks/3-healthcare-stock-stories-for-tuesday-portfolio-wellness.html/?ref=YFyahoo_finance/2004269830Wed, 01 May 2013 12:13:06 GMTRaptor's FDA Approval Is New Test For Orphan Drug Pricinghttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=139kotegp/*http://www.thestreet.com/story/11910401/1/raptors-fda-approval-is-new-test-for-orphan-drug-pricing.html?puc=yahoo&cm_ven=YAHOOyahoo_finance/1536166138Wed, 01 May 2013 11:51:00 GMTWhy Raptor Pharmaceuticals Shares Spiked and Then Droppedhttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13aksv73o/*http://www.fool.com/investing/general/2013/04/30/why-raptor-pharmaceuticals-shares-spiked-then-drop.aspx?source=eogyholnk0000001yahoo_finance/2091250799Tue, 30 Apr 2013 22:25:00 GMT3 Pharmaceutical Companies Awaiting FDA Approval, Part IIhttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=132ub7bkp/*http://seekingalpha.com/article/1386361-3-pharmaceutical-companies-awaiting-fda-approval-part-ii?source=yahooyahoo_finance/2589243820Tue, 30 Apr 2013 20:47:26 GMTRaptor Drug Wins U.S. Approval to Treat Rare Diseasehttp://us.rd.yahoo.com/finance/external/bloomberg/rss/SIG=13el4d0nm/*http://www.bloomberg.com/news/2013-04-30/raptor-wins-fda-approval-for-drug-to-treat-metabolism-error-1-.html?cmpid=yhooyahoo_finance/728962182Tue, 30 Apr 2013 20:36:33 GMTRaptor Pharmaceutical's PROCYSBI™ Receives FDA Approval for the Treatment of Nephropathic Cystinosishttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/raptor-pharmaceuticals-procysbi-receives-fda-195100500.html[PR Newswire] - NOVATO, Calif., April 30, 2013 /PRNewswire/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) ...yahoo_finance/3105624166Tue, 30 Apr 2013 19:51:00 GMTUPDATE 1-U.S. FDA approves Raptor's drug for nephropathic cystinosishttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=12c8ldj54/*http://www.reuters.com/article/2013/04/30/raptor-fda-idUSL2N0DH27T20130430?feedType=RSS&feedName=hotStocksNews&rpc=43yahoo_finance/3151855441Tue, 30 Apr 2013 17:02:00 GMTExpert Analyst Ian Somaiya Discusses the Decline in European Drug Pricing with The Wall Street Transcript; Models a 1% to 2% Annual Decline in Price for Companies That Sell Overseashttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/expert-analyst-ian-somaiya-discusses-154900161.htmlyahoo_finance/2637914441Tue, 30 Apr 2013 15:49:00 GMT